Log In
Print
BCIQ
Print
Print this Print this
 

AzaSite

Also known as: ISV-401

  Manage Alerts
Collapse Summary General Information
Company InSite Vision Inc.
Description1% azithromycin with InSite's DuraSite ophthalmic drug delivery system
Molecular Target Ribosomal 50S subunit
Mechanism of ActionProkaryotic protein synthesis inhibitor
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentMarketed
Standard IndicationConjunctivitis
Indication DetailsTreat acute bacterial conjunctivitis; Treat bacterial conjunctivitis
Regulatory Designation

Partner

Akorn Inc.; Pfizer Inc.; Senju Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today